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p21During embryogenesis, muscle and bone develop in close temporal and spatial proximity. We show that
Indian Hedgehog, a bone-derived signaling molecule, participates in growth of skeletal muscle. In Ihh−/−
embryos, skeletal muscle development appears abnormal at embryonic day 14.5 and at later ages through
embryonic day 20.5, dramatic losses of hindlimb muscle occur. To further examine the role of Ihh in
myogenesis, we manipulated Ihh expression in the developing chick hindlimb. Reduction of Ihh in chicken
embryo hindlimbs reduced skeletal muscle mass similar to that seen in Ihh−/−mouse embryos. The reduction
in muscle mass appears to be a direct effect of Ihh since ectopic expression of Ihh by RCAS retroviral infection
of chicken embryo hindlimbs restores muscle mass. These effects are independent of bone length, and occur
when Shh is not expressed, suggesting Ihh acts directly on fetal myoblasts to regulate secondary myogenesis.
Loss of muscle mass in Ihh null mouse embryos is accompanied by a dramatic increase in myoblast apoptosis
by a loss of p21 protein. Our data suggest that Ihh promotes fetal myoblast survival during their differentiation
into secondary myoﬁbers by maintaining p21 protein levels.r, Cellular, and Developmental
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Vertebrate limb skeletal muscle originates from muscle precursor
cells that migrate into the developing limb bud from limb level
somites (Brand-Saberi and Christ, 2000). Muscle formation is
achieved by two waves of differentiation, primary and secondary
myogenesis, mediated by embryonic and fetal myoblasts, respectively
(Biressi et al., 2007a, 2007b; Duprez, 2002; Tajbakhsh, 2009). Early in
limb development (chick embryonic day (ED)3 to ED7; mouse ED10.5
to ED12.5), embryonicmyoblasts predominate. These cells: (i) require
conditioned media for clonal growth, (ii) differentiate into small
ﬁbers with few nuclei in culture, and (iii) form primary muscle ﬁbers
in vivo (Biressi et al., 2007a, 2007b; Butler et al., 1982; Cossu et al.,
1989; Rutz et al., 1982; Seed and Hauschka, 1984; Seed and Hauschka,
1988). Later in development (chick ED6 to ED13; mouse ED14.5 to
ED20.5), fetal myoblasts predominate (Zappelli et al., 1996). These
cells differ from embryonic myoblasts by: (i) no requirement of
conditioned media for clonal growth, (ii) an ability to form large
multinucleated myotubes in culture, (iii) the initial formation of small
“secondary” myoﬁbers adjacent to established primary myoﬁbers in
vivo, and (iv) in gene expression proﬁles (Biressi et al., 2007a, 2007b;
Stockdale, 1992; Wigmore and Dunglison, 1998; Zappelli et al., 1996).Understanding the roles of signaling molecules that regulate
embryonic and fetal myoblasts in vivo has been possible, in part from
retroviral manipulation of gene expression in the developing chick
embryo (Bren-Mattison and Olwin, 2002; Edom-Vovard et al., 2001;
Flanagan-Steet et al., 2000; Mitchell et al., 2002; Wang et al., 2010).
Among the several growth factors shown to regulate muscle is Sonic
hedgehog (Shh). Previously,wehave shown that Shh regulates terminal
differentiation of embryonic myoblasts located in the posterior of the
limb during primarymyogenesis (Bren-Mattison and Olwin, 2002). Shh
mRNA is detectable by in situ hybridization only during primary
myogenesis (Bren-Mattison and Olwin, 2002; Goodrich et al., 1996);
however, Indian hedgehog (Ihh), another member of the hedgehog
family, begins to be expressed by developing chondrocytes immediately
preceding secondary myogenesis (Vortkamp et al., 1996). Ihh regulates
long bone development beginning at ED5 in avian embryos and ED12.5
in mouse embryos (Bitgood and McMahon, 1995; Vortkamp et al.,
1996). Previouswork has suggested that organization ofmuscle tissue is
inﬂuenced by skeletal elements (Lanser and Fallon, 1987; Robson et al.,
1994; Yamamoto et al., 1998) and the close proximity of Ihh to the
expanding musculature, make Ihh a candidate for a skeletal-derived
signaling molecule capable of regulating secondary myogenesis.
Here, we present the evidence that bone-derived Ihh is required
for secondarymyogenesis.We show that loss of Ihh expression results
in loss of the majority of skeletal muscle groups and loss of Ptch1
expression. Additionally, we show that down-regulation of Ihh
expression in the developing chick hindlimb causes a loss of skeletal
muscle tissue and phenocopies long bone defects observed in the
Ihh−/−mouse.We propose that Ihh, produced by the developing bone
anlagen, is critical for promoting the survival of differentiating fetal
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skeletal musculature.
Materials and methods
Embryos
Fertilized White Leghorn chick embryos were purchased, embryos
grown, staged and injected as previously described (Flanagan-Steet
et al., 2000). Ihh+/− mice were provided by Valerie Wallace (Ottawa
Health Research Institute). Ptch1+/nLacZ (Ptch1tm1Mps/J) mice were
purchased from The Jackson Laboratory. Embryos were harvested
following timed pregnancies (the morning a vaginal plug was
detected was considered day 0.5).
Viral constructs and production
RCAS(BP)A-Nkx-3.2 was provided by Andrew Lassar and RCAS
(BP)A-Ihh was provided by Cliff Tabin. Primary chicken embryo
ﬁbroblasts were isolated from ED12 chick embryos grown, transfected
and virus isolated as previously described (Flanagan-Steet et al.,
2000).
Whole-mount immunohistochemistry
Fixation and preparation of tissue for whole-mount immunohis-
tochemistry were as previously described (Bren-Mattison and Olwin,
2002). A monoclonal pan anti-myosin antibody, MF20 (Developmen-
tal Studies Hybridoma Bank (Bader et al., 1982)) was used with
staining performed as described previously (Bren-Mattison and
Olwin, 2002; Flanagan-Steet et al., 2000).
Section immunohistochemistry and immunoﬂuorescence
Embryoswere harvested in cold PBS, then ﬁxedwith 4% PFA at 4 °C
for 12 h and washed with PBS before being incubated in 15% sucrose
for 12 h, followed by incubation in 30% sucrose for 12 h. Embryos
were then embedded in OCT Compound (Tissue-Tek) and sectioned at
8 μm using a cryostat (Leica). X-gal staining was performed by
Premier Laboratory, LLC, Longmont, CO. For immunoﬂuorescence,
slides containing sections were washed with PBS to remove OCT, then
blocked with 5% goat serum and 0.1% Triton X-100 for 1 h at room
temperature. Sections were then incubated in primary antibody (anti-
Desmin supernatant (Developmental Studies Hybridoma Bank (Ip,
1983); 1:2, anti-myosin heavy chain (MF20) 1:10 for 1 h at 37 °C, and
washed three times for 30 min with blocking solution at room
temperature. Sections were then incubated in appropriate secondary
antibodies Alexa Fluor 594-conjugated (Molecular Probes; 1:500) and/
or FITC-conjugated (Promega Corp.; 1:100) for 1 h at room temperature.
Coverslips were mounted over sections using Vectashield ﬂuorescent
mount media containing 4′,6-diamidino-2-phenylindole (DAPI, Vector
Laboratories).
Whole-mount in situ hybridization
Embryos were harvested at stages speciﬁed in text and ﬁxed in 4%
PFA at 4 °C for 12 h. Whole-mount in situ hybridization was
performed as previously described (Wilkinson and Nieto, 1993)
with the following exception, older embryos (HH 26–27)were treated
with 40 mg/ml Proteinase K for 15 min at room temperature.
Digoxigenin (DIG) -labeled riboprobes were made as previously
described (Wilkinson and Nieto, 1993). Plasmids used to generate
cShh were provided by Dr. Cliff Tabin (Harvard University). Plasmids
used to generate cMyoD-DIG labeled riboprobes for in situ hybridi-
zation were provided by Dr. Bruce Paterson (National Institutes of
Health).Skeletal muscle harvest, wet mass determination and measurement of
bone length
Wild type and Ihh null embryos were harvested in cold PBS. For
wet mass determinations, the left and right hindlimbs were removed,
and weighed using an analytical balance. Following measurement of
each whole limb, epidermis and connective tissue of the limb was
removed and limb muscle was removed from the cartilage/bone
elements using number ﬁve forceps andmuscle mass was determined
with an analytical balance. Bone length measurements were made
using a transparent ruler and a stereoscope dissecting microscope. To
extract proteins, the muscle tissue was removed as described above
and placed in lysis buffer containing protease inhibitors (Pierce). The
tissue was homogenized, vortexed several times, and incubated on ice
for 1 h, centrifuged at 10,000 g for 15 min at 4 °C, aliquots ﬂash frozen
in liquid N2 and stored at −70 °C. Protein concentrations were
determinedwith the Pierce Commassie 200 Plus protein assay reagent
using a bovine serum albumin standard curve as a reference. The
embryo genotypes were readily detected by morphology and
genotypes conﬁrmed by PCR (St-Jacques et al., 1999).Gel electrophoresis and Western Blotting
Protein extracts (20 μg) fromwild type and Ihh null embryos were
boiled in SDS-PAGE sample buffer and separated on 4–20% SDS-PAGE
gradient gels for 2–3 h at 85 V in a Bio-Rad Mini-Protean II gel
apparatus. Proteins were transferred to PVDF membrane (Bio-Rad)
using a mini-gel transfer apparatus (Bio-Rad) at 30 V overnight at
4 °C. The membrane was placed in PBS containing 5% nonfat dry milk
and 0.1% Triton X-100 (blocking solution) for 1 h. Primary antibodies
for Patched (1:500, Research Diagnostics), p21 (1:100, Santa Cruz
(H-164): sc756; may partially react with p27), and 〈-tubulin (1:1000,
Novus Biologicals) were diluted in the same blocking solution,
incubatedwith themembrane for 1 h at room temperature, andwashed
3 times for 10 min each. Blots were then incubated in appropriate
secondary antibodies anti-mouse-HRP (Promega, 1:5000) or anti-rabbit
HRP (Promega, 1:5000) for 1 h at room temperature, washed once on
blocking solution and 3 times in PBS for 15 min and developed
according to the manufacturer's instructions for Chemiluminescence
(Amersham, Inc.).Quantitative RT-PCR
Hindlimb tissue was harvested from ED16.5 and ED18.5 Ihh−/−
and wild type littermates. Total RNA was extracted and Reverse
Transcription was performed using Superscript III. SYBR green
detection of PCR amplicons was employed using an ABI QT-PCR
machine. Corresponding level of MRF expression was normalized to
18S rRNA abundance levels from the same sample. Primer sequences
for MyoD, Myf5, and Myogenin were previously described (Hannon
et al., 1992). Primer sequences for Ptch1 were previously described
(Liu et al., 2010). Primer sequences for 18S rRNA (FOR 5′GCCGCTA-
GAGGTGAAATTCTTG; REV 5′CTTTCGCTCTGGTCCGTCTT.Apoptosis assay
Cryosections prepared and stained for MyHC using MF20 de-
scribed above for wildtype and Ihh−/− ED16.5 embryos were
processed per manufacturer's instructions to detect cell death using
the Roche Cell Death Detection Kit and apoptotic cells visualized with
TMR Red. Digital deconvolution microscopy and image acquisition
were as described previously (Bren-Mattison and Olwin, 2002).
Positive and negative controls were performed per manufacturer's
instructions.
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Primary chick myoblasts were cultured from chicken embryos,
infected, BrdU labeled and assayed using established procedures as
described previously (Bren-Mattison and Olwin, 2002). Primary
mouse myoblasts were explanted from ED16.5 embryos by dissection
of muscle tissue from hindlimbs digested for 30 min at 37 °C in 400 U/
ml Type I Collagenase (Worthington). Digested tissue was washed
with F12C (F12 media+4 mM CaCl2) with 15% horse serum and 2%
chick embryo extract, titerated with an 18 G needle, and ﬁltered
through a 40 μm ﬁlter. Explanted cells were plated onto a 10 cm tissue
culture plate containing 10 ml of F12C, 15% horse serum and 2% chick
embryo extract and incubated at 37 °C for 45 min. Floating cells were
collected and either 1) directly dried onto gelatin coated coverslips or,
2) plated in 2 ml of media in 6-well tissue culture plates containing
gelatin coated coverslips or, 3) harvested for RNA puriﬁcation and
quantitative PCR (see above). Coverslips were ﬁxed with 4%PFA either
immediately after drying onto coverslips or following overnight
incubation at 37 °C. For immunoﬂuorescence, cells were permeabi-
lized with 0.5% Titron-X 100 in PBS for 5 min. Cells were blocked by
incubation in 5% BSA for 1 h at room temperature, incubated with
anti-MyoD antibodies (1:10, Vector Laboratories, clone 5.8A, VP-
M669) or anti-Myogenin antibodies(neat, F5D mouse monoclonal),
and anti-Ptch1 antibodies (1:100, Santa Cruz Biotechnology, sc-6149)
overnight at 4 °C, then washed and incubated with either anti-mouse
Alexa Fluor 555 or anti-goat Alexa Fluor 488, raised in donkey (1:500).
As a negative control, coverslips were incubated with secondary
antibodies alone. Images acquired with a Zeiss ABSO2 confocal
microscope.Fig. 1. Ptch1 is expressed in muscle tissue and Ihh−/− embryos lose hindlimb skeletal mu
(C) ED18.5. Hindlimb cross-sections (8 μm) were stained with a pan MyHC antibody to de
(D) Lysates of skeletal muscle tissue from ED16.5 Ihh null and wild type littermates were we
control. (E and F) Hindlimb sections were assessed for Ptch1 expression inmuscle tissue. (E)
and X-gal. (F) Hindlimbs from ED16.5 Ptch1+/nLacZ heterozygous littermates were sectioned a
is enlarged in order to show X-gal+ (blue) muscle tissue (the black spot is an artifact). Dash
positive (F).Results
Ihh is required for normal muscle development and Ptch1 receptor
expression in muscle
Roles for Shh regulation of primary myogenesis have previously
been reported (Bren-Mattison and Olwin, 2002; Duprez et al., 1998;
Kruger et al., 2001). Based on these studies the observed effects of Shh
overexpression on skeletal muscle occurring later in development
(during secondary myogenesis) were presumed to be either indirect
since Shh expression is not detectable following primary myogenesis,
or from another hedgehog possibly involved in skeletal muscle
development. Since Ihh expression in the bone anlagen begins during
secondary myogenesis, we asked if Ihh null mice exhibited pheno-
types consistent with a role for Ihh in developing muscle.
We observed a dramatic loss of skeletal muscle tissue during
secondary myogenesis in Ihh null limbs as compared to wild type
limbs (Fig. 1). At ED14.5, near completion of primary myogenesis,
Ihh−/− muscle is morphologically distinct from wild type littermates
with mutant muscle groups localized to the limb periphery rather
than around the developing bone (Fig. 1A). However, it appears that
the amount of differentiated muscle is similar in both wild type and
Ihh−/− ED14.5 embryos (Fig. 1A). By ED16.5, Ihh−/− embryo
hindlimbs have lost most of their differentiated muscle compared to
wild type littermate hindlimbs (Fig. 1B). Older mutant embryo
hindlimbs from ED18.5 (Fig. 1C) through ED20.5 (data not shown),
consistently possess less muscle tissue than wild type control
hindlimbs. Unfortunately, we were unable to examine embryos
beyond ED20.5 because Ihh−/− animals are not viable.scle. Wild type and Ihh−/− littermates were harvested at (A) ED14.5, (B) ED16.5, and
tect all differentiated skeletal muscle. F and T mark the ﬁbula and tibia, respectively.
stern blotted for the presence of Ptch1 protein and alpha tubulin was used as a loading
Hindlimbs from ED16.5 wild type mice were sectioned and stained with nuclear fast red
nd stained with nuclear fast red and x-gal to detect beta-galactosidase expression. Inset
ed lines outline developing muscle tissue (E) and muscle tissue that is β-galactosidase-
489Y. Bren-Mattison et al. / Developmental Biology 356 (2011) 486–495Hedgehogs are capable of both short range and long range
signaling (Gritli-Linde et al., 2001; Gualeni et al., 2010; Koziel et al.,
2004; Lewis et al., 2001; Zeng et al., 2001) and signal via the Patched 1
receptor (Lum and Beachy, 2004). Since Ptch1 provides a sensitive
readout of hedgehog activity (Goodrich et al., 1996), we predicted
that if muscle receives direct Ihh signaling, Ptch1 would be expressed
in developing skeletal muscle. To test this, skeletal muscle tissue was
harvested from ED16.5 wild type and Ihh−/− hindlimbs. Western
blots were probed for Ptch1; and as expected, Ptch1 is present in wild
type but not Ihh−/− hindlimb muscle on ED16.5 (Fig. 1D). To further
support that Ptch1 is expressed in muscle, we examined at ED16.5
β-galactosidase activity in heterozygous Ptch1+/nLacZ embryos, in
which β-galactosidase expression is under the control of the Ptch1
regulatory elements. Sections from control (wild type) and Ptch1+/nLacZ
embryos were stained with nuclear fast red and X-Gal to detect
β-galactosidase activity. Cross sections through the lower hindlimb
clearly show no β-gal activity in wild type control embryos (Fig. 1E);
whereas in Ptch1+/nLacZ embryos, β-gal activity was observed (Fig. 1F).
Magniﬁed images from cross sections revealed that the majority of
β-galactosidase activity is present in the perichondrium, as expected
(Fig. 1F). However, distinct loci of β-galactoside activity were seen in
developing skeletal muscle (Fig. 1F). Ptch1 message is present in
primary myoblasts as cells explanted from ED16.5 muscle enriched for
myoblasts by pre-plating and subjected to quantitative PCR are positive
for Ptch1 message (Supplemental 1A). Myoblasts, immunoreactive forFig. 2. Ihh regulates secondary myogenesis. Cross sections at the mid-thigh level of hindlim
larger diameter ﬁbers in Ihh null sections. (A) Arrowheads identify smaller secondary myoﬁ
those shown in (A and B) derived from 3 embryos of each genotype were quantiﬁed and t
Myoblasts were explanted from ED20.5 wild type and Ihh−/− hindlimb muscle, plated a
(D)Myotubes and nuclei were visualized by using panMyHC in red and DAPI, respectively. (E
percent of the total number of myotubes.the myogenic markers, MyoD (Supplemental Fig. 1B) and Myogenin
(Supplemental Fig. 1C) were also immunoreactive for Ptch1 (Supple-
mental Fig. 1 B–D), demonstrating that Ptch1 protein is present in
myoblasts. At ED16.5 there is no detectable expression of either Shh or
desert hedgehog in the developing limb and thus Ptch1 expression is
likely due to Ihh signaling (Colnot et al., 2005; Vortkamp et al., 1996).
Ihh regulates fetal myoblasts undergoing secondary myogenesis
The most severe muscle phenotype in the Ihh−/− mouse was
observed at ED16.5, which coincides temporally with high levels of
expression of Ihh in cartilage (Bitgood and McMahon, 1995). At this
developmental age, skeletal muscle is undergoing secondary myo-
genesis, where the bulk of the musculature is forming by fusion of
fetal myoblasts (Biressi et al., 2007a, 2007b). Secondary myoﬁbers
ﬁrst appear as smaller diameter myoﬁbers that use larger primary
myoﬁbers as scaffolds (Duxson and Usson, 1989) (Fig. 2A; arrow-
heads) In Ihh null mice, smaller secondary myoﬁbers were not readily
discernible (Fig. 2B) and when quantiﬁed, the average myoﬁber size
in Ihh−/−mice was signiﬁcantly larger than in wild typemice (Fig. 2C;
p-valueb0.01; n=3). These data support a role for Ihh in regulating
secondary myogenesis.
If Ihh plays a role in secondary myogenesis, and fetal myoblasts are
lacking or impaired in Ihh null mice, we predict that myoblasts
explanted from ED20.5 Ihh null mice would not exhibit characteristicsbs from (A) ED16.5 wild type and (B) Ihh−/− mice stained for MyHC and nuclei reveal
bers in sections from wild type limbs. (C) The ﬁber diameters from sections similar to
he average ﬁber diameter±SEM (standard error of the mean) was plotted (*p≤0.01).
t equal density, cultured for 3 days and assayed for their ability to form myotubes.
) The number of myonuclei per myotube was quantiﬁed and plotted as a function of the
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embryonicmyoblasts are present and all myoblasts are expected to fuse
into large multinucleatedmyotubes (Biressi et al., 2007a, 2007b; White
et al., 1975). Myoblasts explanted from both ED20.5 wild type and
ED20.5 Ihh−/− hindlimbs were able to differentiate in tissue culture
(Fig. 2D); however,myoblasts explanted from Ihh−/−hindlimbs formed
small myotubes containing 3 or fewer nuclei (Fig. 2E). These data
indicate that defects in the Ihh null myoblasts are cell-autonomous and
not due to extrinsic factors in the developing limb. The formation of
small myotubes in culture (Vivarelli et al., 1988;White et al., 1975) and
the larger diameter of Ihh null myoﬁbers in vivo (Biressi et al., 2007b;
Condon et al., 1990; Kelly and Zacks, 1969; Wigmore and Dunglison,
1998), are all consistentwith the hypothesis that secondarymyogenesis
is altered in Ihh−/− embryos.Manipulation of Ihh expression using retroviral mediated gene
transduction in chick
A complete loss of Ihh severely affects long bone development
(St-Jacques et al., 1999) likely inﬂuencing thedevelopingmusculature. To
test whether Ihh signaling directly affects skeletal muscle development,
we either augmented or reduced Ihh levels in the developing chicken
embryo (Petropoulos and Hughes, 1991). In an attempt to decouple long
bone development and myogenesis, we aimed to reduce rather than
eliminate Ihh expression. Identiﬁcation of an appropriate shRNA that
would reduce rather than eliminate Ihh and that could be rescued in vivo
proved technically difﬁcult. Therefore,we opted to reduce Ihh expression
by using retroviral-mediated gene expression and infecting the devel-
oping bone region with RCAS(BP)A-Nkx3.2 (Fig. 3A).Fig. 3. Reduction of Ihh expression results in decreased skeletal muscle mass and long bone
region of the hindlimb. (B) On ED12, the limbs were sectioned and an anti-sense Ihh-DIG pro
hindlimbs were injected with RCAS(BP)A-Nkx3.2 at ED3 and harvested at ED12. (C)Whole-m
a decrease in girth across the lower limb compared to the contralateral uninfected limb. (D) E
hindlimbs. (E) Forced expression of Nkx3.2 signiﬁcantly reduces whole limb weight, wet mu
ED6 and harvested on ED12. Both the injected limb and the contralateral control limb w
normalized to the contralateral control±SEM were plotted (*p≤0.01; n=9).Nkx3.2 and its mouse homolog Bapx1 belong to a family of
homeodomain transcription factors related to Drosophila bagpipe
(McMahon, 2000; Tribioli and Lufkin, 1999) which is expressed in
prechondrogenic cells that will eventually give rise to bone as well as
the muscle sheath and surrounding mesenchyme tendons (Church
et al., 2005). Overexpression of Nkx3.2 reduces Ihh expression by
preventing the maturation of chondrocytes (Provot et al., 2006).
When injected into the central region of the developing hindlimb on
ED3, RCAS(BP)A-Nkx3.2 reduced Ihh expression levels on ED12
(Fig. 3B). Injection of RCAS(BP)A-Nkx3.2 throughout the entire limb
severely reduced Ihh expression sometimes to undetectable levels
(data not shown), similar to that previously observed (Provot et al.,
2006).
To ensure that ectopic Nkx3.2 effects were mediated via re-
ductions in Ihh, we ﬁrst asked if Shh was affected. Over expression of
Nkx3.2 in the hindlimb of ED3 embryos did not signiﬁcantly alter or
reduce Shh expression (Supplemental Fig. 2A). This ﬁnding agrees
with previous studies examining the role of Bapx1; in Bapx1−/−mice
transcript levels of either Shh or Gli2, a downstream component of
Shh-mediated signaling, are not signiﬁcantly altered (Tribioli and
Lufkin, 1999). Since Shh has been shown to regulate MyoD
expression, and to further rule out the possibility that Nkx3.2 affects
Shh expression, we assessed whether Nkx3.2 overexpression altered
MyoD during primary myogenesis. Two days after RCAS(BP)A-Nkx3.2
injection into ED3 hindlimbs, we examined the distribution of MyoD
mRNA. In situ analysis revealed that ectopic expression of Nkx3.2 and
its subsequent inhibition of Ihh did not signiﬁcantly alter MyoD
expression levels during primary (early) myogenesis (Supplemental
Fig. 2B). These results, together with our previous ﬁnding that forced
expression of Nkx3.2 does not appear to alter Shh distribution orlength. (A) Chick hindlimbs were injected with RCAS(BP)A-Nkx3.2 at ED3 in the mid-
be was used to detect Ihh expression following low-dose viral injection. (C and D) Chick
ount immunohistochemistry for MyHC shows decreases in individual muscle sizes and
xtensor muscles (arrows) are not detectable byMyHC staining in Nkx 3.2 infected lower
scle weight and bone length. Chick hindlimbs were injected with RCAS(BP)A-Nkx3.2 on
ere removed and weighed (see Materials and methods). Average percent difference
491Y. Bren-Mattison et al. / Developmental Biology 356 (2011) 486–495levels of expression, suggest thatNkx3.2 down-regulates Ihh expression
without affecting Shh expression or primary myogenesis.Reduction of Ihh expression signiﬁcantly reduces muscle mass and bone
length
RCAS(BP)A-Nkx3.2 injection of ED3 chick embryos into the mid-
region of the hindlimb reduced the size of the musculature at ED12
(Fig. 3C). Effects on distal muscles appeared more prominent than on
proximal muscles since extensors in the lower hindlimb were difﬁcult
to identify (Fig. 3D). We quantiﬁed whole limb and muscle mass of
embryos injected on ED3 and found signiﬁcant decreases when
infected with RCAS(BP)A-Nkx3.2 compared to uninfected contralat-
eral controls (Supplemental Fig. 3A), while injection of a control virus
had no detectable effect (Bren-Mattison and Olwin, 2002). To conﬁrm
that reduction of Ihh expression reduces muscle in the absence of Shh,
we injected chick hindlimbs with RCAS(BP)A-Nkx3.2 at a time point
(ED6; Fig. 3E) when endogenous Shh expression was undetectable
and quantiﬁed whole limb and muscle masses. Injection of RCAS(BP)
A-Nkx3.2 into hindlimbs at ED6 signiﬁcantly reduced whole limb
mass by 12% and muscle mass by 28% (Fig. 3E). Consistent with
regulation of long bone development by Ihh in mice (St-Jacques et al.,
1999), we observed that RCAS(BP)A-Nkx3.2 injection into ED3
(Supplemental Fig. 3B) and ED6 hindlimbs (Fig. 3E) shortened long
bones by 8%. Therefore, we were unable to deﬁnitively conclude that
the loss of muscle following RCAS(BP)A-Nkx3.2 injection was not an
indirect effect of bone length reduction.Fig. 4. Ectopic Ihh expression increases skeletal muscle mass and rescues Nkx3.2-mediated
and harvested on ED12. Ectopic expression of Ihh increased average whole limb mass and
p≤0.01; n=9±SEM). (B) Schematic of co-injection procedure used for rescue of RCAS(B
hindlimbs were injected in the mid-region with Nkx3.2 expressing virus. After 24 h, an Ihh
hindlimb and embryos were maintained until ED10. (C) Whole-mount immunohistochem
decreased individual muscle size; however, subsequent infection with RCAS-Ihh rescued li
muscle mass loss in Nkx3.2 infected limbs. Average percent difference of Nkx3.2/Ihh co-infec
were plotted (*p≤0.01; n=5±SEM). (E) Chick hindlimbs were injected with RCAS(BP
contralateral control, RCAS-Nkx3.2 injected, and Nkx3.2/Ihh co-infected limbs (as in D) at ED
p≤0.05; for muscle * is p≤0.01; n=3±SEM).Overexpression of Ihh IncreasesMuscleMasswithout Affecting Bone Length
Ectopic expression of Nkx3.2 reduces Ihh mRNA levels suggesting
that overexpression of Ihh should increase muscle mass; however, we
wanted to target developing muscle without affecting long bone
length. By injecting RCAS(BP)A-Ihh into the ﬂanks of ED6 developing
hindlimbs, we were able to decouple muscle mass regulation and
bone length (Fig. 4A). We observed signiﬁcant increases of 23% in
whole limb and 27% in muscle masses independent of long bone
length (Fig. 4A).
If the reduction in muscle mass after RCAS(BP)A-Nkx3.2 infection
was due to loss of Ihh expression, then ectopic Ihh expression should
rescue the muscle mass. Thus, we attempted to rescue RCAS(BP)A-
Nkx3.2 infected hindlimbs by overexpressing Ihh. Since Ihh is
produced in condensing chondrocytes, both limbs were ﬁrst infected
in the medial region of the limb with RCAS(BP)A-Nkx3.2 at ED3, in
order to allow viral replication, infection, and reduction of Ihh
(Fig. 4B). Subsequently, RCAS(BP)A-Ihh was injected 24 h later into
the anterior and posterior regions of one limb to target the developing
muscle (Fig. 4B). Both Nkx3.2 and Ihh viruses used were RCAS-A
subtypes and could not simultaneously infect the same cells (Hughes
et al., 1997), therefore this injection scheme establishes a boundary
where neighboring cells ectopically express either Nkx3.2 or Ihh.
Comparison of co-infected limbs with contralateral limbs injected
onlywith Nkx3.2 demonstrated that ectopic Ihh expression effectively
rescued Nkx3.2-inducedmuscle loss (Fig. 4C and D).Whole mounts of
hindlimbs at ED10 stained for pan skeletal muscle MyHC demonstrate
that the majority of muscles appear intact and that the hindlimb girthloss of skeletal muscle mass. (A) Hindlimbs were injected with RCAS(BP)A-Ihh on ED6
muscle mass without affecting long bone length (for whole limb and muscle mass * is
P)A-Nkx3.2 infected limbs with RCAS(BP)A-Ihh. At ED3, both the left and right chick
virus was injected both anteriorly and posteriorly to the site of Nkx3.2 injection in one
istry for MyHC of Nkx3.2 and Nkx3.2/Ihh infected hindlimbs. RCAS-Nkx3.2 infection
mb girth and individual muscle sizes (arrows). (D) RCAS-Ihh rescued whole limb and
ted whole limb andwet muscle weight normalized to Nkx3.2 infected contralateral limb
)A-Nkx3.2 on ED3 and harvested on ED10. Average muscle mass from uninfected
10 were plotted (uninfected vs. Nkx3.2 single infection; for ED10 harvest whole limb * is
492 Y. Bren-Mattison et al. / Developmental Biology 356 (2011) 486–495has been restored (Fig. 4C). When quantiﬁed, Nkx3.2/Ihh co-infection
resulted in signiﬁcant increases in whole limbmass of 58% andmuscle
mass of 65% when compared to the singly infected Nkx3.2
contralateral limb (Fig. 4D). In order to further assess the ability of
RCAS-Ihh to rescue loss of muscle mediated by forced Nkx3.2
expression, we compared increases in whole limb and muscle masses
of Nkx3.2/Ihh co-infected limbs to an uninfected control. Consistent
with the prior data (Fig. 3), RCAS-Nkx3.2 injection on ED3 with
harvest on ED10 signiﬁcantly decreased whole limb (Supplemental
Fig. 4) and muscle masses (Fig. 4E). Conversely, Nkx3.2/Ihh co-
infection signiﬁcantly increasedwhole limb (Supplemental Fig. 4) and
muscle masses when compared to an uninfected ED10 limb (Fig. 4E).
Co-infection of an empty control virus with Nkx3.2 did not rescue theFig. 5. Ihh-mediated signaling promotes myoblast survival. (A) Quantitative PCR analysis w
ED16.5 or ED18.5. Muscle regulatory factor (MRF) expression levels were normalized t
(B) Schematic of experiment: wild type chick myoblasts explanted at ED12 were either infec
to differentiation medium and maintained for an additional 72 h. Prior to ﬁxation, cells were
proliferating and differentiated cells, respectively. (C) The data were quantiﬁed and the aver
per ﬁeld (30 ﬁelds scored per condition; 3 independent experiments; for total nuclei p≤0.05
red, anti-MyHC in green and DAPI. (D) Hindlimb cross sections obtained from ED16.5 wild
apoptotic cells, and stained for MyHC to detect differentiated muscle (green). Arrows in w
protein extracts were obtained from ED16.5 wild type and Ihh−/− hindlimb muscle, separate
in Ihh null extracts. Alpha-tubulin was used as a loading control.loss in muscle mass, further demonstrating that the rescue of muscle
mass is speciﬁc to Ihh (data not shown).
Ihh promotes myoblast cell survival
Our data support the hypothesis that Ihh regulates long bone
development concomitantlywith secondarymyogenesis. Ihh regulation
of secondary myogenesis could be mediated via several mechanisms
including promotion of fetal myoblast proliferation, enhanced survival,
or promotion of terminal differentiation. Alternatively, Ihh null muscle
may be deﬁcient in muscle regulatory factor expression effectively
blocking progression through myogenesis. To better understand the
mechanisms involved, we quantiﬁed expression of Myf5, MyoD, andas performed on cDNA from wild type littermates and Ihh null hindlimbs harvested on
o 18S rRNA and plotted as the average±SEM. (n≥3 embryos for each timepoint)
ted with RCAS(BP)A-Ihh or RCAN control virus. After 24 h in culture, cells were switched
pulsed with BrdU for 1 h and then stained with antibodies to BrdU and MyHC to detect
age number of total nuclei, % BrdU+, and % of nuclei in myotubes±SEMs were plotted
; for % of nuclei in myotubes p≤0.01). Inset micrographs were stained with anti-BrdU in
type and Ihh−/− mouse embryos were ﬁxed, and subjected to TUNEL (red) to detect
ild type sections indicate the small number of TUNEL positive cells. (E) Muscle tissue
d by SDS-PAGE andWestern blotted. p21 protein was detected in wild type but reduced
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neither Myf5, MyoD nor Myogenin is deﬁcient in Ihh null muscle when
compared to wild type littermates (Fig. 5A).
Since loss of Ihh expression does not alter myogenic transcription
factor expression, we further explored the mechanisms responsible
for the effects of exogenous Ihh by examining fetal myoblast
proliferation and differentiation. If Ihh acts as a classic mitogen,
such as EGF, or a repressor of myogenesis similar to the FGFs or Shh
(Bren-Mattison and Olwin, 2002; Clegg et al., 1987; Rheinwald and
Green, 1977), then exogenous Ihh should either promote proliferation
or inhibit myogenesis in fetal myoblasts under conditions that would
normally promote cell cycle exit and differentiation. Chick fetal
myoblasts were explanted, infected with RCAS(BP)A-Ihh or RCAN
control virus in growth medium for 24 h and then switched to
differentiation medium for an additional 48 h (Fig. 5B). Prior to
ﬁxation, the cells were pulsed for 1 h with BrdU. The cultures were
then scored for the total number of nuclei per ﬁeld, percentage of
BrdU+ cells and percent nuclei in myotubes positive for MyHC. We
observed no signiﬁcant difference in the percentage of BrdU+ cells
(Fig. 5C); therefore, we conclude that Ihh does not act as a fetal
myoblast mitogen. Interestingly, infection with RCAS-Ihh promoted
differentiation without a corresponding decrease in the total number
of nuclei per ﬁeld, which would be expected if Ihh promoted cell cycle
exit (Fig. 5C). Since Hedgehogs are known to function as survival
factors in other developing systems (Ahlgren and Bronner-Fraser,
1999; Varjosalo and Taipale, 2008), these data are consistent with Ihh
promoting survival of fetal myoblasts undergoing differentiation. It is
well established that myoblasts undergoing differentiation exhibit
higher rates of apoptosis and that survival factors enhance muscle
differentiation (Stewart and Rotwein, 1996; Wang and Walsh, 1996).
If Ihh functions to enhance fetal myoblast survival, loss of muscle
tissue in Ihh null mice could be due to increased cell death. TUNEL
assays performed on ED16.5 wild type and Ihh−/−muscle tissue show
virtually undetectable levels of TUNEL reactivity in wild type muscle
(Fig. 5D). In contrast, a high level of TUNEL activity was observed in
Ihh−/− muscle tissue (Fig. 5D). To further probe the mechanisms
involved, we assayed for the presence of p21 in muscle tissue
undergoing secondary myogenesis. Upregulation of p21 is critical for
normal myoblast cell-cycle exit (Guo et al., 1995; Halevy et al., 1995;
Wang and Walsh, 1996) and confers resistance to apoptosis in
myoblasts committed to differentiate (Fujio et al., 1999; Lawlor and
Rotwein, 2000; Ostrovsky and Bengal, 2003; Wang and Walsh, 1996).
When probed for p21 protein, Western blots of extracts from ED16.5
Ihh−/− muscle tissue reveal a dramatic difference in the level of p21.
While p21 is readily detectable in wild type skeletal muscle, it is
virtually undetectable in Ihh null muscle tissue (Fig. 5E). Thus, Ihh
signaling appears to promote survival of fetal myoblasts undergoing
terminal differentiation during secondary myogenesis.Discussion
Vertebrate limb musculature develops in close proximity and
concurrently with bone. Bone can develop normally in the absence of
muscle, since muscleless mouse mutants exhibit no obvious hindlimb
skeletal defects (Nowlan et al., 2010). Since bone is necessary for
insertion of skeletal muscle tendons and acts as a scaffold for muscle
development (Marieb, 1998), it seems unlikely that muscle could
develop appropriately in the absence of bone. Signals directingmuscle
patterning are normal in the absence of myoblasts (Kardon et al.,
2003), implying that muscle development is inﬂuenced by the
surrounding tissues. Here, we present evidence demonstrating that
Ihh, a skeletal-derived factor, is involved in skeletal muscle develop-
ment. We propose that Ihh is required for survival of the fetal
myoblast population; and thus, Ihh appears to coordinate outgrowth
of the skeleton with growth of the skeletal musculature.Requirement of Ihh for secondary but not primary myogenesis
Loss of Shh dramatically affects skeletal muscle development during
primary myogenesis (Bren-Mattison and Olwin, 2002; Duprez et al.,
1998; Kruger et al., 2001); and inhibition of Shh affects muscle
development as early as ED5 in the chicken embryo (Bren-Mattison
andOlwin, 2002). Conversely, inhibitionor loss of Ihhdoesnotdetectably
alter muscle development until ED10–12 in the chicken and ED16.5 in
mouse, indicating that Shh and Ihh act on temporally distinct myogenic
cell populations. Consistent with this idea is the observation that
secondary but not primary myogenesis appears affected in Ihh−/−mice
and is supported by the following experimental observations: myoﬁber
diameters in Ihh−/− cross sections are signiﬁcantly larger than myoﬁber
diameters of wild type mice; and smaller, secondary myoﬁbers, readily
visible in wild type sections, are rare or absent in sections from Ihh−/−
embryos. Additionally, Ihh null myoblasts appear to have a cell
autonomous defect as explanted myoblasts from Ihh−/− ED20.5 mouse
embryos form myotubes possessing few nuclei.
Ihh regulates muscle mass independently from bone length
Ihh regulates long bone length through inhibition of the rate of
chondrocyte differentiation (Vortkamp et al., 1996); and loss of Ihh
results in severe shortening of long bones (St-Jacques et al., 1999).
However, our analysis of the Ihh null mouse could not address
whether loss of muscle was an indirect consequence of shorter limbs.
Consequently, we used retroviruses to either augment or inhibit Ihh
expression in the developing chicken hindlimb. To accomplish this,
Nkx 3.2 was ectopically overexpressed in the developing limb bud.
Although artiﬁcial, this allowed a reduction rather than elimination of
Ihh to further test the requirement of Ihh in muscle development
without the confounding effects on bone development. Thus,
reduction of Ihh expression in chick hindlimb caused a 6% decrease
in long bone length with a concurrent 30% decrease in muscle weight.
The 6% decrease in bone length was much less severe than the
65% decrease in long bone length reported for the Ihh null mouse
(St-Jacques et al., 1999) Ihh overexpression signiﬁcantly increased
muscle mass without affecting long bone length. These data and the
observations that Ptch1 is expressed in developing muscle and in fetal
myoblasts, suggest that Ihh regulates muscle mass independently of
bone length and that long-range Ihh signaling is involved as the primary
source of Ihh is the perichondrium (Ayers et al., 2010; Etheridge et al.,
2010; Yan et al., 2010). Long-range Ihh signaling is dependent on
heparan sulfate proteoglycans (Ayers et al., 2010; Yan et al., 2010),
which are also involved in skeletal muscle development and regener-
ation (Casar et al., 2004; Cornelison et al., 2001; Cornelison et al., 2004;
Olguin et al., 2003; Olguin and Brandan, 2001). These data and the
observations that (i) Ptch1 is expressed in developingmuscle, (ii) Ptch1
mRNA is in fetal myoblasts, (iii) Ptch1 protein is present in fetal
proliferating myoblasts and committed myocytes, and (iv) fetal
myoblasts are Ihh responsive support a direct role for Ihh signaling in
skeletal muscle development.
Cellular signaling mediated by Ihh
Skeletal muscle development requires the coordinated effort of four
muscle transcription factorswhere the severe loss ofmuscle in the Ihh−/
−mice could be due to alterations in the timing of muscle transcription
factor expression or in their expression levels. We observed normal
levels and timing of Myf5, MyoD and Myogenin expression in Ihh null
hindlimb muscle, indicating that myogenic speciﬁcation and early
stages of differentiation appearnormal. Addition of Ihh towild type fetal
myoblast cultures signiﬁcantly increases differentiated nuclei without a
corresponding decrease in total nuclei, suggesting that Ihh enhances the
survival of myoblasts committed to differentiate rather than promoting
cell cycle exit and terminal differentiation. A similar role has been well
494 Y. Bren-Mattison et al. / Developmental Biology 356 (2011) 486–495documented for p21, a cyclin dependent kinase inhibitor. Loss of p21
from skeletal muscle myoblasts increases apoptosis only in myoblasts
committed to terminal differentiation, thereby reducing the number of
differentiated nuclei (Wang and Walsh, 1996). These data support a
model whereby Ihh is required for survival of fetal myoblasts
undergoing terminal differentiation. Loss of Ihh may result in apoptosis
of differentiating myoblasts which in turn would reduce the number
myoﬁbers in developingmuscle tissue, resulting in catastrophic muscle
loss. In agreement with this idea, we observe a dramatic increase in
TUNEL staining of Ihh−/− hindlimb sections in regions where muscle is
present in wild type littermates. Furthermore, our data support a direct
role for Ihh in fetal myoblast survival since Ihh directly affects fetal
myoblasts in culture, and Patched 1 protein, a direct readout of Ihh
signaling, is present in wild type but not Ihh null muscle tissue. Loss of
Ihh in myoblasts may induce apoptosis since the Patched 1 receptor in
the absence of ligand can function as a dependence receptor (Thibert et
al., 2003). In addition, the loss of Ihh appears to affect p21 expression in
muscle tissue, enhancing apoptosis of differentiating cells which in turn
results in reduction of differentiated muscle. In summary, our data
provide evidence supporting a role for Ihh in regulating skeletal muscle
development during secondary myogenesis where Ihh appears to
maintain and promote the survival of fetal myoblasts undergoing
myogenic differentiation.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.06.002.
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